A 91-year-old man was admitted to the hospital with weight loss, dyspnea, and eosinophilia. An anteroposterior chest radiograph obtained 2 months earlier showed bibasilar patchy opacities. A ...
The U.S. Food and Drug Administration (FDA) has approved Filkri (filgrastim-laha), a biosimilar to Neupogen (filgrastim), to ...
Multiple myeloma is a cancer that occurs when a type of white blood cell grows out of control, causing low blood counts, bone and calcium problems, frequent infections and kidney damage. According to ...
A new study reveals that the predictive power of key inflammatory markers, such as C-reactive protein, shifts fundamentally depending on whether a patient suffers from cirrhosis or acute/chronic ...
Skidaway Island resident Bruce Koehler is among early participants seeing clinical blood‑count improvements in a nationwide prevention study ...
Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax (R) for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...
CLL is staged from 0 to 4 using the Rai system based on factors like lymphocyte count and organ enlargement. The earlier stages of CLL, like stage 0 and stage 1, often have a good prognosis and slow ...
When you are dying, at least in my limited experience, you start remembering everything. Images come in flashes—people and places and stray conversations—and refuse to stop. I see my best friend from ...
DEAR DR. ROACH: My husband was diagnosed with chronic lymphocytic leukemia (CLL) in 2010 and remained in stage 2 with no effects until 2022. In the interim, he was also diagnosed with atrial ...
CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced new paradigm changing findings from the Phase 2 QUILT-3.055 study, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results